Skip to content

Effects of Yuan-Luo Da Jiejing Method Combined with Repetitive Transcranial Magnetic Stimulation (rTMS) on Post-Stroke Complex Regional Pain: A Randomized Controlled Trial

Effects of Yuan-Luo Da Jiejing Method Combined with Repetitive Transcranial Magnetic Stimulation (rTMS) on Post-Stroke Complex Regional Pain: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001677
Enrollment
Unknown
Registered
2025-09-04
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex regional pain after stroke

Interventions

control group:Plain acupuncture and Repetitive Transcranial Magnetic Stimulation
control group:Only Repetitive Transcranial Magnetic Stimulation
test group:Yuan-Luo Da Jiejing Method and Repetitive Transcranial Magnetic Stimulation

Sponsors

Nanbu County People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 2.2 Diagnostic criteria meet the diagnostic criteria for stroke and the diagnostic criteria for complex regional pain. (1) Diagnostic criteria for stroke (meeting 1) or 2)) 1) Diagnostic criteria for cerebral infarction: Referring to the Chinese Guidelines for the Diagnosis and Treatment of Acute-phase Ischemic Stroke 2014 formulated by the Cerebrovascular Disease Group of the Neurology Section of the Chinese Medical Association, the following criteria were met: acute onset of the disease, focal neurological deficits, and in a minority of cases, comprehensive neurological deficits; the symptoms and signs lasted for more than 24 hours; non-vascular brain lesions were ruled out; cerebral CT or MRI excludes other lesions, and there is a responsible ischaemic focus. 2) Diagnostic criteria for cerebral haemorrhage: Refer to the Chinese Guidelines for the Diagnosis and Treatment of Cerebral Haemorrhage formulated by the Neurology Section of the Chinese Medical Association in 2014, and meet the following criteria (acute onset is not required): acute onset of symptoms of focal neurological deficits (a few of which are symptoms of comprehensive neurological deficits), often accompanied by headache, vomiting, elevated blood pressure, and varying degrees of impaired consciousness; disclosure of haemorrhagic foci on CT or MRI; exclusion of non-vascular cerebral causes. vascular brain causes. (3) Diagnostic criteria for complex regional pain: Refer to the "Budapest criteria" of the International Association of Pain (IASP), and those who meet the criteria and have no obvious evidence of peripheral nerve injury can be diagnosed as CRPS-type I. 2.3 Inclusion criteria (1) Age =18 years, gender is not limited; (2) Compliance with the diagnosis of stroke and complex regional pain according to the diagnostic criteria; (3) Vital signs of the subjects were stable; (4) Patients and their families signed an informed consent form; (5) The patient had no consciousness disorder and was able to understand the operator's instructions.

Exclusion criteria

Exclusion criteria: (1)Diagnosis of CRPS Type 2 or documented pre-stroke CRPS history. (2)Presence of current limb fracture local infection or peripheral neuropathy in the affected extremity. (3)Concomitant severe aphasia unilateral neglect or cognitive impairment. (4)History of recurrent stroke brainstem/cerebellar lesions or bilateral involvement. (5)Implantation of metal/electronic medical devices (e.g. cardiac pacemakers) epilepsy history or intracranial hypertension. (6)Identified coagulopathy needle phobia or skin lesions at acupuncture points. (7)Comorbid central post-stroke pain phantom limb pain or other chronic pain syndromes. (8)Concurrent severe psychiatric disorders. (9)Opioid usage or receipt of interventional pain therapy within 4 weeks prior to enrollment. (10)Pregnancy lactation or concurrent participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Pain intensity;

Secondary

MeasureTime frame
Shoulder mobility assessment;Strength of functional connectivity in pain-related brain regions;Degree of muscle spasm;Quantitative assessment of motor function of the upper and lower limbs;Evaluation of the stages of motor function recovery in the limbs on the hemiplegic side;Incidence of adverse events;Patient's ability to perform activities of daily living;Blind assessment;Assessment of body surface temperature distribution in the region of pain;

Countries

China

Contacts

Public ContactLIU Huan

Nanbu County People's Hospital

416614890@qq.com19982820882

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026